Krystal Biotech Inc
(KRYS)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 16,501 | 932 | 10,932 | 2,240 | -78,507 |
| Depreciation Amortization | 3,630 | 1,609 | 5,911 | 4,154 | 2,789 |
| Accounts receivable | -61,196 | -4,427 | -42,040 | -9,316 | N/A |
| Accounts payable and accrued liabilities | 1,511 | 727 | -101 | 121 | 481 |
| Other Working Capital | -26,992 | 6,301 | -38,522 | -12,498 | -3,010 |
| Other Operating Activity | 78,266 | 10,746 | -24,984 | -66,273 | 17,901 |
| Operating Cash Flow | $11,720 | $15,888 | $-88,804 | $-81,572 | $-60,346 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -42,942 | -24,720 | -5,563 | 2,750 | -4,223 |
| PPE Investments | -2,391 | -1,260 | 88,201 | 90,048 | -8,171 |
| Investing Cash Flow | $-45,333 | $-25,980 | $82,638 | $92,798 | $-12,394 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 26,607 | 15,969 | 203,499 | 200,880 | 187,492 |
| Other Financing Activity | -5,386 | -5,386 | -749 | -749 | -749 |
| Financing Cash Flow | $21,221 | $10,583 | $202,750 | $200,131 | $186,743 |
| Exchange Rate Effect | -150 | 187 | -156 | -16 | -28 |
| Beginning Cash Position | 358,328 | 358,328 | 161,900 | 161,900 | 161,900 |
| End Cash Position | 345,786 | 359,006 | 358,328 | 373,241 | 275,875 |
| Net Cash Flow | $-12,542 | $678 | $196,428 | $211,341 | $113,975 |
| Free Cash Flow | |||||
| Operating Cash Flow | 11,720 | 15,888 | -88,804 | -81,572 | -60,346 |
| Capital Expenditure | -2,391 | -1,260 | -11,799 | -9,952 | -8,171 |
| Free Cash Flow | 9,329 | 14,628 | -100,603 | -91,524 | -68,517 |